OP14 Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE studyWilliam J. Sandborn, Edward V. Loftus, Fabio Cataldi et al.|Journal of Crohn s and Colitis|2019Cited by 9
OP024 Long-term safety and efficacy of the anti-MAdCAM monoclonal antibody SHP647 for the treatment of Crohn’s disease: the OPERA II studyGeert D’Haens, William J. Sandborn, Walter Reinisch et al.|Journal of Crohn s and Colitis|2018Cited by 6
OP08 Long-term efficacy and pharmacodynamics of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) monoclonal antibody SHP647 in Crohn’s disease: the OPERA II studyG. D’Haens, W. Sandborn, Walter Reinisch et al.|Journal of Crohn s and Colitis|2019Cited by 3